Mylan’s generic of Allergan's vaginal estrogen cream Estrace gets FDA nod
December 30, 2017 No Comment
Mylan has secured the US FDA approval for Estradiol Vaginal Cream USP, 0.01%, the generic version of Allergan’s vaginal estrogen cream – Estrace for the treatment of vulvar and vaginal atrophy. Following the approval of the vaginal estrogen cream, Mylan has announced the launch of Estradiol Vaginal Cream in the US. A condition that normally […]
Continue reading …
Eli Lilly and Company, which is better known as Lilly, says that a late-stage trial of Cyramza (ramucirumab) for the treatment of a form of gastric cancer met its primary goal of stopping the disease from advancing, but failed in improving overall survival. An antiangiogenic therapy, ramucirumab in combination with cisplatin and capecitabine or 5-FU […]
Continue reading …ViiV Healthcare secures Juluca FDA approval for virologically suppressed HIV-1
November 25, 2017 No Comment
Juluca FDA approval : ViiV Healthcare’s 2-drug regimen Juluca has secured approval from the US Food and Drug Administration (FDA) for the maintenance treatment of virologically suppressed human immunodeficiency virus type 1 (HIV-1) infection. The HIV drug regimen Juluca, which is intended to be taken as a single pill daily once, is a combination of […]
Continue reading …
Acalabrutinib FDA approval : AstraZeneca has secured an early approval for its blood cancer drug Calquence (acalabrutinib) for the treatment of mantle cell lymphoma in adult patients who were subjected to a minimum of one prior therapy for the rare type of blood cancer. According to the National Cancer Institute at the National Institutes of […]
Continue reading …Kite Car T therapy Yescarta bags FDA approval for type of lymphatic cancer
October 19, 2017 No Comment
Yescarta FDA approval : Kite Pharma has bagged the US FDA approval for its chimeric antigen receptor T cell (CAR T) therapy Yescarta (axicabtagene ciloleucel) for a type of lymphatic cancer (Lymphoma). FDA Approves New Lymphoma Drug Yescarta The Car T therapy from the Gilead subsidiary will be available as a new treatment option in […]
Continue reading …AstraZeneca lung cancer drug Tagrisso gets FDA breakthrough therapy designation
October 15, 2017 No Comment
Pharma news updates : Tagrisso (osimertinib), the AstraZeneca lung cancer drug has bagged the breakthrough therapy designation (BTD) from the US FDA for the treatment of non-small cell lung cancer (NSCLC) in a first line setting. The BTD designation for the AstraZeneca cancer drug is specifically for treating metastatic NSCLC patients who have tested positive […]
Continue reading …
Luxturna FDA approval news : Luxturna (voretigene neparvovec), a gene therapy from Spark Therapeutics is closing in towards an FDA approval for treating blindness due to an inherited retinal disease (IRD), following the recommendation from an advisory panel of the US drug regulator. An adeno-associated viral (AAV) vector gene therapy, Luxturna has been recommended to […]
Continue reading …Novo Nordisk bags insulin aspart injection Fiasp FDA approval for diabetes
October 2, 2017 No Comment
Fiasp FDA approval : Danish pharmaceutical company Novo Nordisk has secured the US FDA approval for its new fast-acting mealtime insulin aspart injection Fiasp 100 Units/mL for diabetes treatment in adults. Already approved in Canada and Europe, Fiasp is the addition of two excipients to Novo Nordisk’s insulin aspart (NovoLog) in a new formulation with […]
Continue reading …Abemaciclib FDA approval : Lilly breast cancer drug gets regulatory nod
September 30, 2017 No Comment
Abemaciclib FDA approval : Eli Lilly and Company (Lilly) has secured the US FDA approval for Verzenio (abemaciclib) to treat metastatic breast cancer in patients whose disease had progressed after a prior treatment. Abemaciclib FDA Approval The breast cancer drug approval is for patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 […]
Continue reading …Ajanta Pharma gets USFDA approval for Entacapone, Parkinson’s disease tablet
September 4, 2017 No Comment
Ajanta Pharma got the final USFDA approval for Entacapone tablets which is used for treating the Parkinson’s disease. Ajanta Pharma said that it has received the final approval for Entacapone tablets from US FDA in a BSE filing. Entacapone tablets are bioequivalent generic version of Comtan tablets. Ajanta Pharma company said that they will launch […]
Continue reading …
Business News Today
- Chinese lifestyle product retailer MINISO opens new store in Madrid
- Unilever to acquire Los Angeles-based SmartyPants Vitamins
- Bega Cheese to acquire Lion Dairy & Drinks for $412m
- Nestlé to sell Yinlu peanut milk and canned rice porridge businesses in China
- TEXRail extension project : Trinity Metro selects AECOM as project consultant
- Castle Mountain Gold Mine California : Equinox Gold achieves commercial production
- McCormick to acquire Mexican hot sauce brand Cholula Hot Sauce
- Elliott Advisors offers to take over Swiss food company Aryzta for CHF0.8 per share
- US challenger bank Current raises $131m in Series C round
- HelloFresh to acquire US meal delivery service provider Factor75
